You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-Interferon gamma antibodySee all Interferon gamma primary antibodies ...
  • Description
    Rabbit polyclonal to Interferon gamma
  • Tested applicationsWB, ELISA, Neutralising, ICC/IF, IHC-P more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Highly pure (>98%) recombinant hIFN-gamma (human Interferon-gamma).

Properties

Applications

Our Abpromise guarantee covers the use of ab9657 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use at an assay dependent concentration. To detect hIFN-gamma by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIFN-gamma is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
ELISA ELISA: Use at an assay dependent concentration. Can be paired for ELISA with Mouse monoclonal to Interferon gamma (ab9658). To detect hIFN-gamma by direct ELISA (using 100µl/well antibody solution) a concentration of at least 0.5µg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with compatible secondary reagents, allows the detection of 0.2 - 0.4 ng/well of recombinant hIFN-gamma.
Neutralising Neut: Use at an assay dependent concentration. To yield one-half maximal inhibition [ND50] of the biological activity of hIFN-gamma (50 pg/ml), a concentration of 0.04 - 0.06 ng/ml of this antibody is required.
ICC/IF ICC/IF: Use at an assay dependent concentration.
IHC-P IHC-P: Use a concentration of 0.25 - 0.5 µg/ml.

Target

  • FunctionProduced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons.
  • Tissue specificityReleased primarily from activated T lymphocytes.
  • Involvement in diseaseIn Caucasians, genetic variation in IFNG is associated with the risk of aplastic anemia (AA) [MIM:609135]. AA is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.
  • Sequence similaritiesBelongs to the type II (or gamma) interferon family.
  • Post-translational
    modifications
    Proteolytic processing produces C-terminal heterogeneity, with proteins ending alternatively at Gly-150, Met-157 or Gly-161.
  • Cellular localizationSecreted.
  • Target information above from: UniProt accession P01579 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      IFG antibodyIFI antibodyIFN Gamma antibody
      IFN Immune antibodyIFN-gamma antibodyIFNG antibodyIFNG antibodyIFNG_HUMAN antibodyImmune Interferon antibodyInterferon gamma antibodyInterferon Gamma Precursor antibodyMacrophage Activating Factor antibodyMAF antibodyT Cell Interferon antibodyType II Interferon antibody
    see all

Anti-Interferon gamma antibody images

  • ab9657 staining Interferon gamma in human cervical squamous cell carcinoma section by Immunohistochemistry (Formalin/PFA fixed paraffin-embedded sections). Tissue underwent heat mediated antigen retrieval in sodium citrate buffer (pH 6.0). The primary antibody was used at 0.25 ug/ml and incubated with sample at 4°C overnight. A HRP-labeled polymer detection system was used with a DAB chromogen

References for Anti-Interferon gamma antibody (ab9657)

This product has been referenced in:
  • Tanaka A  et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum 64:254-63 (2012). IHC-P ; Human . Read more (PubMed: 21898360) »
  • Belogurov AA  et al. Liposome-encapsulated peptides protect against experimental allergic encephalitis. FASEB J : (2012). IHC . Read more (PubMed: 23047895) »

See all 6 Publications for this product

Product Wall

Displaying 1 - 7 of 7 results for Abreviews and Q&A

All of these antibodies recognise cytokines which are present in inflammed tissue therefore any inflammed tissue would be a good positive control.

In our catalogue, we have several cancer slides which would be appropriate:
tonsil: (ab5146) ...

Read More
Application Immunocytochemistry/ Immunofluorescence
Sample Cow Cell (mammary gland lymph node)
Specification mammary gland lymph node
Fixative Formaldehyde
Permeabilization No
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 10% · Temperature: 25°C
Username

Verified customer

Submitted Mar 02 2012

A good alternative to tonsil is spleen and also tissue from the digestive tract, for instance colon or small intestine.

Thank you for your enquiry. This antibody is sold at 100 ug per vial. We woudl recommend to reconsitute this in 200 ul of sterile distilled water. This will provide a stock concentration of 0.5 mg/ml. With regards to isotype, this antibody is a polyclonal...

Read More

Thank you for your enquiry. As far as we know only the pH 6 citrate buffer has been tested as a retrieval buffer for use with ab9657. It is certainly possible that a different pH buffer will also work, however we do not have any experimental data to sp...

Read More
Application Western blot
Sample Human Recombinant protein (Recombinant human IFN-gamma)
Loading amount 3 µg
Specification Recombinant human IFN-gamma
Gel Running Conditions Reduced Denaturing (4-20)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C
Username

Verified customer

Submitted Apr 09 2009

Thank you for your enquiry. This antibody is sourced externally to Abcam. I have been in touch with the source of this antibody. From the information that I have been provided with I can tell you that this antibody was tested at a concentration of 0.2...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"